Akebia Therapeutics (NASDAQ:AKBA) Upgraded by Piper Sandler

Piper Sandler upgraded shares of Akebia Therapeutics (NASDAQ:AKBA – Get Rating) from a neutral rating to an overweight rating in a research note released on Wednesday, The Fly reports. A number of other brokerages have also issued reports on AKBA. StockNews.com lowered Akebia Therapeutics from a buy rating to a hold rating in a research […]

Related Keywords

Michel Dahan , Steven Keith Burke , Piper Sandler , Metlife Investment Management , Hightower Advisors , Securities Exchange Commission , Jpmorgan Chase Co , Akebia Therapeutics Inc , Akebia Therapeutics Company Profile , Mirabella Financial Services , Icon Wealth Partners , Akebia Therapeutics , Get Rating , Keith Burke , Exchange Commission , Wealth Partners , Financial Services , Tower Advisors , Life Investment Management , Akebia Therapeutics Daily , Nasdaq Akba , Nakba , Medical , Upgrade ,